Le Lézard
Classified in: Health
Subjects: PDT, MAT

Strainprinttm Technologies Ltd. Launches the Strainprint Community - an Online Forum Providing Cannabis Education and Resources to Coincide With Legalization in Canada


The Online Space Offers a Safe Space for Cannabis Enthusiasts and the Canna-Curious to Share Information, Overcome Obstacles, Create Opportunities and Unite as a Community

TORONTO, Oct. 16, 2018 /CNW/ - Strainprinttm Technologies Ltd launched the Strainprint Community, Cannabis in Good Company today - a real-time, online platform that provides education and support for the growing cannabis community. The site aims to help both veteran and new users to navigate through the historical transition to legalized cannabis in Canada.

Strainprint Technologies Ltd. (CNW Group/Strainprint Technologies Ltd.)

Built by patients for patients, Strainprint started off by providing a free medical cannabis tracking app. The app powers Strainprint Analytics, which provides anonymized, invaluable, crowd-sourced data to clinics, pharmacies, licensed producers, researchers, physicians, government, and the entire cannabis industry. With more than 800,000 anonymous personal health records and 30 million data points, Strainprint Analytics is the leading source of medical cannabis data in all of North America.

With the same patient-centric spirit and realization for the need for sound educational tools in mind, Strainprint created the Strainprint Community. The objective was to leverage their data insights and industry influence to become the go-to source for everything cannabis related. The Community features up-to-date information, educational tools, articles, news, event listings, recipes, private groups, and discussion forums - all provided in a safe, moderated and stigma-free environment.

"As Canada ventures into this new world of legalization, there will be a lot of questions and curiosity. The Strainprint Community is a space for people to ask questions, learn, connect, share ideas and support one another," said Strainprint Co-Founder and Chief Creative Officer, Stephanie Karasick. "We're lucky to be living in a country at a time where we get to see the end of prohibition. However, it's going to take some time for many people to believe that cannabis isn't the dangerous drug we were told it was. We have a lot of information and conversation available for everyone from the canna-curious to the most knowledgeable people in the industry."

To get started, simply sign up for free at strainprint.ca/community. Once enrolled, members can ask questions or start new conversations in dozens of open topic specific forums, or they can request to have their own private spaces in groups. Strainprint anticipates anyone from consumers, to medical researchers, to clinics, to doctors, to cancer patients, and everyone in between, will come looking for open and honest discussions, continuing education, support and mentorship.

"As patients ourselves, we understand that the information available to cannabis users can be confusing and overwhelming, regardless of one's' level of experience. We believe that providing an inclusive, compassionate space for diverse groups of people will unite the community with common goals of sharing resources and knowledge," said Ashleigh Brown, Community Manager and Patient Liaison. "If people from all walks of life connect through our community to share their cannabis journeys, and if they can be empowered through education and engagement, then we know we have helped people use cannabis better."

To begin the journey visit https://strainprint.ca/community 

About Strainprinttm
Founded in Toronto in 2016, Strainprinttm Technologies Ltd. is the leading demand-side cannabis data and analytics company. With the world's largest longitudinal, observational data-set of its kind and a mission to advance the scientific understanding of cannabis and its legitimization as a mainstream therapy, Strainprint helps medical cannabis patients and doctors to use cannabis in the most effective and responsible way possible. Strainprinttm data supports global cannabis research and provides advanced business intelligence and treatment guidance to producers, retailers, medical practitioners, pharmacies, government and industry. Strainprint is HIPAA, PIPEDA and PHIPA privacy compliant, military-grade encrypted and all patient data is completely anonymized and at rest in Canada. Strainprint can be seamlessly embedded or integrated with most electronic medical records (EMR) and seed2sale software systems.  Strainprint Analytics is accessed by customer subscription. The Strainprint App is free to patients and can be downloaded from both the iOS App Store and GooglePlay Storewww.strainprintanalytics.com. facebook, twitter, linkedin.

Strainprint Community (CNW Group/Strainprint Technologies Ltd.)

SOURCE Strainprint Technologies Ltd.


These press releases may also interest you

at 06:30
Johnson & Johnson today announced that its Board of Directors has declared a 4.2% increase in the quarterly dividend, from $1.19 per share to $1.24 per share, marking the 62nd year of consecutive increases. At the new rate, the indicated dividend...

at 06:30
The Functional Food Ingredients Market was valued at USD 119.2 billion in 2024, showcases a remarkable growth projection, anticipated to escalate to USD 165.8 billion by 2029, indicating a robust compound annual growth rate (CAGR) of 6.8% from 2024...

at 06:30
According to Future Market Insights (FMI), the...

at 06:30
Héma-Québec is proud to announce a new partnership with CIUSSS de l'Estrie?CHUS, CIUSSS de la Mauricie-et-du-Centre-du-Québec and CHU de Québec?Université Laval that will provide the institutions with a local point person specially dedicated to human...

at 06:25
Johnson & Johnson today announced results for first-quarter 2024. "Johnson & Johnson's solid first quarter performance reflects our sharpened focus and the progress in our portfolio and pipeline," said Joaquin Duato, Chairman and Chief Executive...

at 06:20
The new research gives a complete picture of the Chagas Disease: American trypanosomiasis market. It looks at trends in the CD market, including how common it is in different regions, and talks...



News published on and distributed by: